Trial Profile
Leukocyte and Platelet Rich Plasma Versus Type A Botulinum Toxin Versus Glucocorticoids for the Treatment of Lateral Epicondylalgia: a Randomized, Multicenter, Double-blind, Therapeutic Trial With Three Parallel Arms
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Glucocorticoids (Primary)
- Indications Tennis elbow
- Focus Therapeutic Use
- Acronyms LET
- 16 Jun 2017 Status changed from recruiting to discontinued due to stop production PRB kit.
- 17 Dec 2015 Planned end date changed from 1 Oct 2018 to 1 Jun 2018, as reported by ClinicalTrials.gov.
- 17 Dec 2015 Planned primary completion date changed from 1 Oct 2018 to 1 Jun 2018, as reported by ClinicalTrials.gov.